Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis

References

• RisauWMechanisms of angiogenesisNature199738666266716749109485
   PubMed Web of Science ®Google Scholar
• SledgeGWJrMillerKDAngiogenesis and antiangiogenic therapyCurr Probl Cancer200226116011961506
   PubMed Web of Science ®Google Scholar
• MuthukkaruppanVRKubaiLAuerbachRTumor-induced neovascularization in the mouse eyeJ Natl Cancer Inst19826936997086180212
   PubMedGoogle Scholar
• SachdevJCJahanzebMEvolution of bevacizumab-based therapy in the management of breast cancerClin Breast Cancer20088540241018952553
   PubMed Web of Science ®Google Scholar
• SalterJTMillerKDAntiangiogenic agents in breast cancerCancer Invest200725751852618027149
   PubMed Web of Science ®Google Scholar
• LiuDShriverZVenkataramanGEl ShabrawiYSasisekharanRTumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasisProc Natl Acad Sci U S A200299256857311805315
   PubMed Web of Science ®Google Scholar
• IozzoRVSan AntonioJDHeparan sulfate proteoglycans: heavy hitters in the angiogenesis arenaJ Clin Invest2001108334935511489925
   PubMed Web of Science ®Google Scholar
• LiuDShriverZQiYVenkataramanGSasisekharanRDynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycansSemin Thromb Hemost2002281677811885027
   PubMed Web of Science ®Google Scholar
• SasisekharanRVenkataramanGHeparin and heparan sulfate: bio-synthesis, structure and functionCurr Opin Chem Biol20004662663111102866
   PubMed Web of Science ®Google Scholar
• SasisekharanRShriverZVenkataramanGNarayanasamiURoles of heparan-sulphate glycosaminoglycans in cancerNat Rev Cancer20022752152812094238
   PubMed Web of Science ®Google Scholar
• NiersTMKlerkCPDiNisioMMechanisms of heparin induced anti-cancer activity in experimental cancer modelsCrit Rev Oncol Hematol200761319520717074500
   PubMed Web of Science ®Google Scholar
• ChoiYJLeeJYParkJHThe identification of a heparin binding domain peptide from bone morphogenetic protein-4 and its role on osteogenesisBiomaterials201031287226723820621352
   PubMed Web of Science ®Google Scholar
• ShonSKKimAKimJYKimKIYangYLimJSBone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cellsBiochem Biophys Res Commun2009385219820319450561
   PubMed Web of Science ®Google Scholar
• TsuchidaROsawaTWangFBMP4/thrombospondin-1 loop paracrinically inhibits tumor angiogenesis and suppresses the growth of solid tumorsOncogene201433293803381124013228
   PubMed Web of Science ®Google Scholar
• XuJZhuDSonodaSOver-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9Angiogenesis201215221322722392094
   PubMed Web of Science ®Google Scholar
• CardinADWeintraubHJMolecular modeling of protein-glycosaminoglycan interactionsArteriosclerosis19899121322463827
   PubMedGoogle Scholar
• FahamSHilemanREFrommJRLinhardtRJReesDCHeparin structure and interactions with basic fibroblast growth factorScience19962715252111611208599088
   PubMed Web of Science ®Google Scholar
• HilemanREFrommJRWeilerJMLinhardtRJGlycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteinsBioessays19982021561679631661
   PubMed Web of Science ®Google Scholar
• UtoguchiNMizuguchiHDantakeanAEffect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagenBr Journal Cancer19967312428
   Web of Science ®Google Scholar
• ChoiYSLeeJYSuhJSThe systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamineBiomaterials20103161429144319954842
   PubMed Web of Science ®Google Scholar
• NeufeldGCohenTGengrinovitchSPoltorakZVascular endothelial growth factor (VEGF) and its receptorsFASEB J19991319229872925
   PubMed Web of Science ®Google Scholar
• ZiyadSIruela-ArispeMLMolecular mechanisms of tumor angiogenesisGenes Cancer20112121085109622866200
   PubMedGoogle Scholar
• DoggrellSAPegaptanib: the first antiangiogenic agent approved for neovascular macular degenerationExpert Opin Pharmacother2005681421142316013991
   PubMed Web of Science ®Google Scholar
• WedamSBLowJAYangSXAntiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancerJ Clin Oncol200624576977716391297
   PubMed Web of Science ®Google Scholar
• SarrazinSLamannaWCEskoJDHeparan sulfate proteoglycansCold Spring Harb Perspect Biol201137a00495221690215
   PubMed Web of Science ®Google Scholar
• DedesPGGialeliCTsonisAIExpression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acidBiochim Biophys Acta20121820121926193922884656
   PubMed Web of Science ®Google Scholar
• MalavakiCJRoussidisAEGialeliCImatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cellsFEBS J2013280102477248923374223
   PubMed Web of Science ®Google Scholar
• FrommJRHilemanRECaldwellEEWeilerJMLinhardtRJPattern and spacing of basic amino acids in heparin binding sitesArch Biochem Biophys19973431921009210650
   PubMed Web of Science ®Google Scholar
• CapilaILinhardtRJHeparin-protein interactionsAngew Chem Int Ed Engl200241339141212491369
   PubMed Web of Science ®Google Scholar
• FrommJRHilemanRECaldwellEEWeilerJMLinhardtRJDifferences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factorArch Biochem Biophys199532322792877487089
   PubMed Web of Science ®Google Scholar
• BellostaPIwahoriAPlotnikovANEliseenkovaAVBasilicoCMohammadiMIdentification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesisMol Cell Biol200121175946595711486033
   PubMed Web of Science ®Google Scholar
• KhachigianLMChestermanCNSynthetic peptides representing the alternatively spliced exon of the platelet-derived growth factor A-chain modulate mitogenesis stimulated by normal human serum and several growth factorsJ Biol Chem199226711747874821559986
   PubMed Web of Science ®Google Scholar
• McCaffreyTAFalconeDJDuBTransforming growth factor-β1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-β1J Cell Physiol199215224304401639873
   PubMed Web of Science ®Google Scholar
• ThompsonSAHigashiyamaSWoodKCharacterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparinJ Biol Chem19942694254125498300582
   PubMed Web of Science ®Google Scholar
• LamaliceLLe BoeufFHuotJEndothelial cell migration during angiogenesisCirc Res2007100678279417395884
   PubMed Web of Science ®Google Scholar
• RisauWFlammeIVasculogenesisAnnu Rev Cell Dev Biol19951173918689573
   PubMed Web of Science ®Google Scholar
• AbediHZacharyIVascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cellsJ Biol Chem19972722415442154519182576
   PubMed Web of Science ®Google Scholar
• OlssonAKDimbergAKreugerJClaesson-WelshLVEGF receptor signalling: in control of vascular functionNat Rev Mol Cell Biol20067535937116633338
   PubMed Web of Science ®Google Scholar
• TakahashiTShibuyaMThe 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblastsOncogene19971417207920899160888
   PubMed Web of Science ®Google Scholar
• GiannelliGFalk-MarzillierJSchiraldiOStetler-StevensonWGQuarantaVInduction of cell migration by matrix metalloprotease-2 cleavage of laminin-5Science199727753232252289211848
   PubMed Web of Science ®Google Scholar
• MatrisianLMWrightJNewellKWittyJPMatrix-degrading metalloproteinases in tumor progressionPrincess Takamatsu Symp1994241521618983072
   PubMedGoogle Scholar
• MurphyANUnsworthEJStetler-StevensonWGTissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferationJ Cell Physiol199315723513587693724
   PubMed Web of Science ®Google Scholar
• PratheeshkumarPKuttanGAndrographolide inhibits human umbilical vein endothelial cell invasion and migration by regulating MMP-2 and MMP-9 during angiogenesisJ Environ Pathol Toxicol Oncol2011301334121609314
   PubMed Web of Science ®Google Scholar
• LiabakkNBTalbotISmithRAWilkinsonKBalkwillFMatrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancerCancer Res19965611901968548762
   PubMed Web of Science ®Google Scholar
• KoskimakiJEKaragiannisEDRoscaEVPeptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenograftsNeoplasia200911121285129120019836
   PubMed Web of Science ®Google Scholar